Merck
  • Home
  • Search Results
  • Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the generation R study.

Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the generation R study.

The Journal of clinical endocrinology and metabolism (2013-09-17)
Tim I M Korevaar, Sarah Schalekamp-Timmermans, Yolanda B de Rijke, W Edward Visser, Willy Visser, Sabine M P F de Muinck Keizer-Schrama, Albert Hofman, H Alec Ross, Herbert Hooijkaas, Henning Tiemeier, Jacoba J Bongers-Schokking, Vincent W V Jaddoe, Theo J Visser, Eric A P Steegers, Marco Medici, Robin P Peeters
ABSTRACT

Premature delivery is an important risk factor for child mortality and psychiatric, metabolic, and cardiovascular disease later in life. In the majority of cases, the cause of prematurity cannot be identified. Currently, it remains controversial whether abnormal maternal thyroid function during pregnancy increases the risk of premature delivery. Therefore, we investigated the relation between maternal serum thyroid parameters and the risk of premature delivery in a large prospective population-based study. Serum TSH, free T4 (FT4), T4, and TPO antibodies (TPOAbs) were determined during early pregnancy in 5971 pregnant women from the Generation R study. Data were available on maternal age, parity, smoking, socioeconomic status, ethnicity, maternal anthropometrics, and urinary iodine levels. Of all women, 5.0% had a premature delivery (<37 weeks), 4.4% had a spontaneous premature delivery, and 1.4% had a very premature delivery (<34 weeks). High TSH levels and subclinical hypothyroidism were associated with premature delivery but not with spontaneous premature delivery. Maternal hypothyroxinemia was associated with a 2.5-fold increased risk of premature delivery, a 3.4-fold increased risk of spontaneous premature delivery, and a 3.6-fold increased risk of very premature delivery (all P < .01). TPOAb positivity was associated with a 1.7-fold increased risk of premature delivery (P = .01), a 2.1-fold increased risk of spontaneous premature delivery (P = .02), and a 2.5-fold increased risk of very premature delivery (P = .04). These effects remained similar after correction for TSH and FT4 levels. Hypothyroxinemia and TPOAb positivity are associated with an increased risk of premature delivery. The increased risk in TPOAb-positive women seems to be independent of thyroid function.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Iodine, puriss., meets analytical specification of Ph. Eur., BP, USP, 99.8-100.5%
Sigma-Aldrich
Iodine, puriss., ≥99.5% (RT), particles (round)
Sigma-Aldrich
Iodine, flakes, ReagentPlus®, ≥99%
Sigma-Aldrich
Iodine, ACS reagent, ≥99.8%, solid
Supelco
Iodine, ReagentPlus®, ≥99.8% (titration)
Sigma-Aldrich
Iodine, ReagentPlus®, 99.7% trace metals basis, beads, 1-3 mm
Sigma-Aldrich
Iodine, Vetec, reagent grade, 99%
Sigma-Aldrich
Iodine, 99.999% trace metals basis
Sigma-Aldrich
Iodine, anhydrous, beads, −10 mesh, 99.999% trace metals basis
Sigma-Aldrich
Iodine, ≥99.99% trace metals basis